1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Recurrent Implantation Failure: new trials by email Literature Review of Recurrent Implantation Failure trials Research Report on Recurrent Implantation Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aromatase Plus GnRH Analogue Versus GnRH Analog Alone in Adenomyosis GnRH analog (11.25mg Leuprolide acetate), Aromatase inhibitor and GnRH analog, Aromatase and GnRH analog (11.25mg Leuprolide acetate) - Uterine Adenomyosis, Recurrent Implantation Failure | Phase 4 | Unknown | Centre for Endocrinology and Reproductive Medicine, Italy | 300 | 2017-12-01 | 2024-03-06 |
Adenomyosis (1) · Dysmenorrhea (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Menstruation Disturbances (1) · Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pelvic Pain (1) · Signs and Symptoms (1) · Urogenital Diseases (1) · Uterine Diseases (1)
Aromatase (1) · Aromatase Inhibitors (1) · Control Groups (1) · Gonadotropin-Releasing Hormone (1) · Leuprolide (1)
Centre for Endocrinology and Reproductive Medicine, Italy (1)
Albania (1) · Bulgaria (1) · Italy (1)